Signal Diagnostics同意支付2050万美元以解决虚假索赔法案的指控
Signal Diagnostics LLC已同意支付2050万美元以解决其涉嫌违反《虚假索赔法》的指控，即通过保留HRSA无保险计划的超额付款。
为什么重要. 此次和解影响了Signal Diagnostics，并凸显了不遵守医疗法规的风险，影响了公司的财务状况和声誉。
01
影响到谁
- 1Signal Diagnostics LLC
- 受监管于 →事实
02
证据
- UUS Department of Justice press监管机构2026-09-30 20:00
Signal Diagnostics LLC (Signal) has agreed to pay the United States $20.5 million to resolve allegations that Signal violated the False Claims Act by knowingly retaining and improperly avoiding its obligations to repay the Health Resources & Services Administration (HRSA) COVID-19 Claims Reimbursement to Health Care
- UUS Department of Justice press监管机构2026-09-30 20:00
Signal Diagnostics LLC (Signal) has agreed to pay the United States $20.5 million to resolve allegations that Signal violated the False Claims Act by knowingly retaining and improperly avoiding its obligations to repay the Health Resources & Services Administration (HRSA) COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for t…
- UUS Department of Justice press监管机构2026-09-30 20:00
Independence Blue Cross (IBX), an insurance company incorporated under the laws of Pennsylvania, has agreed to pay $22.5 million to resolve allegations that it violated the False Claims Act by...